Boston Scientific's new CEO takes office, Watson creates a generics management team
Amgen's former head of North America commercial operations joins Incyte, and pharma veteran James Sapirstein assumes the CEO position at Alliqua.
C-suites at Sanovas, MassBiologics and Spectrum saw shakeups, with new names and new hires.
Stuart Arbuckle, formerly of Amgen, has been named Vertex's EVP and chief commercial officer.
The Alliance for Continuing Education in the Health Professions (ACEHP) named a new executive director, and mobile health app firm Preventice hired a director of global business development.
Everyday Health promoted Ju-Don Roberts to GM and SVP, Symphony Health Solutions hired a new CEO and Quadrant named a new editor-in-chief.
Targacept president and CEO J. Donald deBethizy is resigning from the company "for personal considerations" amid a series of pipeline setbacks.
Longtime Edelman global health leader Nancy Turett is stepping down from her role as chief strategist, health and society at the healthcare PR giant.
Amgen's CEO exits, Bradway steps in, and Pfizer's got a new emerging markets president.
Healthcare consultancy firm, Kantar Health, has promoted two TNS healthcare alumni, NeurOp appoints first CSO.
Michael Chang, chairman of the board at Optimer Therapeutics and Optimer Biotechnology, was removed due to compliance/conflict of interest issues, Optimer said. Chang's replacement on the Optimer board is Hank McKinnell, former CEO of Pfizer.
Andrew Hurd is the new CEO and president of medical information platform developer Epocrates,
Mardene Miller has been named president of the Omnicom's healthcare agency Harrison and Star.
Alkermes appointed its first chief commercial officer, Merck veteran Mark Stejbach.
Novartis named Brian McNamara as division head of OTC, replacing J&J veteran Naomi Kelman, who spent a year in the role.
Elsevier named Jay Katzen managing director for its Clinical Decision Support group.
The Healthcare Businesswomen's Association named Cardinal Health pharma segment chief Michael Kaufmann as its 2012 Honorable Mentor of the year.
The Healthcare Businesswomen's Association named Siren Interactive founder and president Wendy White to its board of directors executive committee.
Teva named former Bristol-Myers Squibb exec Dr. Jeremy Levin to replace Shlomo Yanai, who is retiring from his role as president and CEO of the generics giant in May.
Vertex CEO Matthew Emmens is stepping down from that post after the company's best year ever and amid skyrocketing sales of its hepatitis C drug Incivek.
Pfizer's board of directors elected CEO Ian Read chairman, succeeding George Lorch in that post.
Adrian Adams was appointed CEO and president of Auxilium Pharmaceuticals, effective immediately, succeeding Armando Anido, who, after discussions with the company's board agreed to step down from that role.
Brian McGowan, Pfizer's senior director of education, oncology, in the medical education grants group, said he is leaving the company tomorrow.
Genzyme named William "Bill" Sibold as head of multiple sclerosis and Rogério Vivaldi as head of rare diseases, two businesses the firm says constitute its core focus following the integration with Sanofi.
Muckraking pharma critic Paul Thacker is leaving the Project on Government Oversight, where he has been an investigator for a year since leaving the Senate, to serve as chief of investigations at United Republic.
Lilly named Lilly USA president Dave Ricks SVP and president of Lilly Bio-Medicines, in which role he'll succeed Bryce Carmine, who is retiring.
Boston Scientific named J&J devices chief Michael Mahoney president and, eventually, CEO.
Sunovion Pharmaceuticals has announced that Mark Iwicki, formerly president and chief operating officer at Sunovion, has been appointed as the company's president and CEO.
Sunovion Pharmaceuticals has announced that Mark Iwicki, formerly president and chief operating officer at Sunovion, has been appointed as the company's president and CEO.
Sanofi Pasteur named Chad Hoover VP, chief commercial officer for Sanofi Pasteur US, with responsibility for day-to-day management of commercial operations for the US vaccines business.
GlaxoSmithKline Consumer Healthcare has announced the appointment of John Graham to the position of chief marketing officer (CMO) for Consumer Healthcare, North America (CHNA), which encompasses such consumer brands as Aquafresh and Sensodyne toothpastes and Tums antacid.
Roche named Mara Aspinall president of Ventana Medical Systems.
Michel Nakache has been brought on by McCann Healthcare Worldwide as EVP Europe.
BIO, the Biotech Industry Organization, named Human Genome Sciences chief H. Thomas Watkins chairman of the board for 2011-2012.
The American Medical Association named James Madara EVP and CEO.
Merck KGaA's EMD Serono announced on Friday that president Fereydoun Firouz had resigned from his positions there "to pursue other professional opportunities" after 22 years with the company.
Sanofi Pasteur named Damian Braga global head of commercial operations. Braga, who was previously president of Sanofi Pasteur US and VP Americas, will have responsibility for more than $5 billion in annual revenue from operations in 100 countries in his new post as SVP commercial operations, vaccines.
Boston Scientific president and CEO Ray Elliott will retire on December 31, the company said. A search is on for a replacement.
Porter Novelli named Susan Hayes global director of health, effective immediately.
Seattle Genetics hired Natasha Hernday as VP, corporate development.
Napo Pharmaceuticals hired Neelam Sekhri Feachem as SVP, global access and alliances.
Access Pharmaceuticals hired Anthony Mottola as VP of managed care and market access.
Covidien promoted Jose (Joe) Almeida to president and CEO effective July 1, replacing Richard Meelia, who is retiring.
The American Medical Association named Boston University School of Medicine's Howard Bauchner, MD editor-in-chief of JAMA.
Hospira named Allergan president F. Michael Ball chief executive officer. Ball succeeds founding CEO Christopher Begley, who will become executive chairman at Hospira.
Draftfcb hired Jennifer Comiteau as director of content creation, a new position.
Bayer HealthCare appointed Erica Mann president of its consumer division and a member of its executive committee, effective March 14.
Aqua Pharmaceuticals hired Ted White as VP, sales, responsible for managing Aqua's sales force.
Biocodex USA hired Dr. Andres Tellez as principal, business development and strategy.
Mobile reference firm Epocrates appointed former Pfizer executive Peter Brandt to its board of directors.
Pfizer named GSK's Dr. Yvonne Greenstreet SVP, head of medicines development for its Specialty Care Business Unit.
Microwave ablation firm BSD Medical promoted Steven Smith to VP, sales, marketing and business development, including responsibility for global sales and distribution.
John Johnson, SVP and president of Lilly Oncology, has resigned from the company effective January 28.
Conceptus, a Mountain View, CA-based company that developed a non-surgical permanent birth control procedure, has hired Bayer's Sam Trujilo to head up marketing.
Former FDA commissioner Dr. Lester Crawford, who has worked at a Washington lobbying firm since resigning from the agency in 2005, joined the board of Bexion Pharmaceuticals.
SkinMedica hired Joe Willis as VP, sales and marketing.
Par Pharmaceutical Companies said John MacPhee had resigned as president of Strativa Pharmaceuticals and EVP Par Pharmaceutical "to pursue other interests" after six years with the company.
Pfizer's board of directors elected George Lorch as non-executive chairman of the board.
Medical device firm D. Medical Industries has hired Zoe Myers as chief commercial officer, effective February 1, 2011, to lead global commercial strategy and US operations.
Kenneth Frazier will succeed Richard Clark as CEO of Merck effective January 1, 2011, the company announced this morning.
Regeneron Pharmaceuticals named Christine Poon to its expanded board of directors.
Unigene Laboratories hired Alex Martin as VP, business development and head of commercial operations, a newly created position.
Astellas Pharma's Agensys subsidiary named Allergan's Sef Kurstjens CEO and president, replacing founder Donald Rice, who is retiring.
Porter Novelli named chief medical officer Barbara DeBuono, MD to lead its global healthcare practice.
Lighthouse Learning, which develops and sells CME curricula without taking commercial support, hired Sherri Foster as CME director.
AbelsonTaylor named Nancy Drescher SVP, director of client services.
Market research agency Synovate Healthcare has hired Paul Villa as SVP, payer and market access research.
Catabasis Pharmaceuticals hired Michael Curtis, Ph.D., as VP, product development, a new role.
Signature Diagnostics, a molecular oncology diagnostics company, hired Rainer Kramer as chief business officer.
Aveo Pharmaceuticals hired Michael Bailey as chief commercial officer, a new position.
Waggener Edstrom, the Seattle PR shop, named SVP Colleen Beauregard to lead the healthcare practice.
Catherine DeAngelis will step down from her post as JAMA editor-in-chief next June, the journal said.
APCO Worldwide named former Pfizer public affairs director Francesca Tedesco VP.
HC&B named Digitas Health's Amy Chase senior interactive project manager.
Paul Thacker, a top researcher for Sen. Chuck Grassley (R-IA) whose work transformed regulation of industry marketing practices, is leaving the Senator's office to join the Project on Government Oversight.
Gardiner-Caldwell Communications named AstraZeneca's Richard Baxter VP client services.
Digital healthcare marketing agency Ignite Health, part of inVentiv Health, hired Hana Smetkova as VP, creative director, working out of the agency's Manhattan office.
Nycomed US hired Steve Andrzejewski as CEO, putting him in charge of Nycomed's US dermatology business and distribution and commercial operations for the three marketing and sales divisions Fougera, PharmaDerm and Savage Laboratories.
Everyday Health named Washington Post digital head Goli Sheikholeslami chief product officer.
Nycomed US named Steve Andrzejewski CEO.
Amgen named Novartis' Jonathan Peacock EVP and chief financial officer.
Bayer HealthCare promoted Timothy Hayes to lead global business development for its consumer care division effective July 1, adding to his previous role as SVP and region head for the business unit.
Abbott Laboratories executive vice president of pharmaceuticals Olivier Bohuon is leaving the company to become CEO at Pierre Fabre Group, a French pharmaceutical company, beginning September 1.
Biogen Idec hired Dr. George Scangos as CEO, replacing the recently retired James Mullen.
Spectrum Pharmaceuticals hired James Shields as SVP and chief commercial officer.
Eisai promoted Lonnel Coats to president and CEO of Eisai Inc., from president and COO.
Quadrant HealthCom named Carol Nathan VP, custom programs and Kathy Christie editorial manager, custom programs.
Par Pharmaceutical CFO Lawrence Kenyon resigned effective June 30 "to pursue other opportunities" and will be replaced by treasurer Michael Tropiano, who joined the company in that role in 2005.
APCO Worldwide hired former Wyeth corporate affairs chief Timothy Cost to lead its substantial healthcare practice.
MedImmune named Lisa Davis VP, corporate affairs, with responsibility for PR, internal communications, government affairs, advocacy, community relations and corporate responsibility.
AstraZeneca hired Pfizer's Martin Mackay to lead research and development, and Pfizer named Wyeth R&D chief Mikael Dolsten to lead its R&D efforts.
MS&L announced several hires to its North American healthcare practice, including Ellena Friedman, who joins from Feinstein Kean Healthcare as SVP, director of the healthcare and life sciences practice and deputy managing director in Boston.
Razorfish Health named Alfred O'Neill group VP client engagement and strategy and Rob Ulliman executive creative director.
Sudler & Hennessey named John Marchese EVP, director of account services.
GlaxoSmithKline promoted Patrick Vallance as SVP, medicines discovery and development, and as a member of the company's corporate executive team.
Bill Goldberg was named president and CEO of Healthcare Regional Marketing, a Cincinnati-based marketing services firm that services pharma and healthcare industry clients. He was previously COO of the firm.
Lorraine Bracco will serve as PhRMA's latest celebrity guest for its Sharing Miracles public affairs show.
Avanir Pharmaceuticals named Michael McFadden VP US sales and managed markets, while ur-pharmablogger Ed Silverman quit Elsevier for Canon Communications.
Merck advanced its succession plan for senior management, announcing that Kenneth Frazier, currently president of the Global Human Health worldwide sales and marketing division, has been elected company president by the board of directors.